Back to Deutsche Bank AG Deutsche Bank AG

CLDX

24 quarters

Position history for Deutsche Bank AGDeutsche Bank AG's holdings in Celldex Therapeutics, Inc.

Yes. Deutsche Bank holds 176,592 shares of CLDX (Celldex Therapeutics), worth $6.6M, as of its Q2 2026 13F filing. It increased the position by 33,555 shares (+23.5%) from Q1 2026. Deutsche Bank has held CLDX since Q3 2020, across 24 quarterly 13F filings.

Current Value

$6.6M

Current Shares

176,592

Total Value Change

+$723,989

Total Shares Change

-217,681

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
176,592
+23.5%
$6.6M0.0%$37.21
33
2026-Q1
Increased
143,037
+4.8%
$4.5M0.0%$31.72
28
2025-Q4
Increased
136,485
+1.4%
$3.7M0.0%$27.16
27
2025-Q3
Increased
134,557
+4.7%
$3.5M0.0%$25.87
28
2025-Q2
Decreased
128,581
-7.0%
$2.6M0.0%$20.35
0
2025-Q1
Increased
138,289
+13.8%
$2.5M0.0%$18.15
30
2024-Q4
Increased
121,501
+207.9%
$3.1M0.0%$25.27
43
2024-Q3
Decreased
39,459
-11.3%
$1.3M0.0%$33.99
0
2024-Q2
Decreased
44,483
-3.1%
$1.6M0.0%$37.01
0
2024-Q1
Increased
45,892
+26.4%
$1.9M0.0%$41.97
32
2023-Q4
Decreased
36,315
-2.4%
$1.4M0.0%$39.66
0
2023-Q3
Increased
37,221
+9.4%
$1M0.0%$27.52
27
2023-Q2
Decreased
34,008
-24.6%
$1.2M0.0%$33.93
0
2023-Q1
Increased
45,128
+24.2%
$1.6M0.0%$35.98
31
2022-Q4
Increased
36,323
+8.4%
$1.6M0.0%$44.57
28
2022-Q3
Decreased
33,512
-80.3%
$942,0000.0%$28.11
0
2022-Q2
Increased
170,214
+127.4%
$4.6M0.0%$26.96
43
2022-Q1
Decreased
74,857
-23.5%
$2.6M0.0%$34.06
0
2021-Q4
Increased
97,896
+116.3%
$3.8M0.0%$38.64
43
2021-Q3
Increased
45,259
+30.7%
$2.4M0.0%$53.99
33
2021-Q2
Increased
34,631
+1338.2%
$1.2M0.0%$33.44
41
2021-Q1
Decreased
2,408
-97.1%
$50,0000.0%$20.60
0
2020-Q4
Decreased
82,232
-79.1%
$1.4M0.0%$17.52
0
2020-Q3
New
394,273
-
$5.8M0.0%$14.83
38

Other major holders of CLDX: FMR LLC, Wellington Management Group LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used